Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network. - Heard, Jean-Michel; Vrinten, Charlotte; Schlander, Michael; Bellettato, Cinzia Maria; van Lingen, Corine; Scarpa, Maurizio; the MetabERN collaboration group; Matthijs, Gert; Nassogne, Marie-Cécile; Debray, François-Guillaume; Roland, Dominique; Chamova, Teodora; et al. (Orphanet Journal of Rare Diseases, 2020)